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Abstract
Background: Psychedelics induce intense modifications in the sensorium, the sense of “self,” and the experience of reality. 
Despite advances in our understanding of the molecular and cellular level mechanisms of these drugs, knowledge of their 
actions on global brain dynamics is still incomplete. Recent imaging studies have found changes in functional coupling 
between frontal and parietal brain structures, suggesting a modification in information flow between brain regions during 
acute effects.
Methods: Here we assessed the psychedelic-induced changes in directionality of information flow during the acute effects of 
a psychedelic in humans. We measured modifications in connectivity of brain oscillations using transfer entropy, a nonlinear 
measure of directed functional connectivity based on information theory. Ten healthy male volunteers with prior experience 
with psychedelics participated in 2 experimental sessions. They received a placebo or a dose of ayahuasca, a psychedelic 
preparation containing the serotonergic 5-HT2A agonist N,N-dimethyltryptamine.
Results: The analysis showed significant changes in the coupling of brain oscillations between anterior and posterior 
recording sites. Transfer entropy analysis showed that frontal sources decreased their influence over central, parietal, and 
occipital sites. Conversely, sources in posterior locations increased their influence over signals measured at anterior locations. 
Exploratory correlations found that anterior-to-posterior transfer entropy decreases were correlated with the intensity of 
subjective effects, while the imbalance between anterior-to-posterior and posterior-to-anterior transfer entropy correlated 
with the degree of incapacitation experienced.
Conclusions: These results suggest that psychedelics induce a temporary disruption of neural hierarchies by reducing top-
down control and increasing bottom-up information transfer in the human brain.
Keywords: Oscillatory brain dynamics, psychedelics, functional connectivity, transfer entropy, human
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Introduction
Growing interest in psychedelics or “mind-manifesting” drugs 
as models of disease (Kometer et al., 2011; Carhart-Harris et al., 
2013) and potential therapeutic agents in psychiatry (Sessa, 
2005; Grob et al., 2011) has stimulated new research into their 
neural mechanisms. Evidence of their modulatory capacity on 
the amygdala and ACC suggests their potential efficacy in the 
treatment of affective disorders (Vollenweider and Kometer, 
2010; Kraehenmann et al., 2014). One of the psychedelics whose 
use has expanded most rapidly in recent years is ayahuasca. This 
plant-derived preparation contains N,N-dimethyltryptamine 
(DMT), a classical psychedelic with 5-HT2A agonist properties 
(González-Maeso and Sealfon, 2009). DMT is structurally related 
to the neurotransmitter serotonin (5-hydroxytryptamine) and 
induces brief but intense modifications of the ordinary state of 
awareness (Strassman et al., 1994). Ayahuasca, which contains 
natural monoamine-oxidase inhibitors, induces effects that 
are more prolonged in time, reaching their maximum intensity 
around 1.5 and 2 hours after administration (Riba et al., 2001b, 
2003; Dos Santos et al., 2011).
Recent studies using neurophysiological and neuroimaging 
techniques have advanced our knowledge of the brain areas tar-
geted by psychedelics. Two major brain hubs have been impli-
cated in the effects of these drugs: the medial aspects of the 
frontal cortex including the anterior cingulate cortex (ACC) and 
several regions in the parietal lobes, including the posterior cin-
gulate cortex and dorsolateral parietal cortex (Riba et al., 2004, 
2006; Carhart-Harris et  al., 2012; Muthukumaraswamy et  al., 
2013; Palhano-Fontes et al., 2015). Nuclear medicine techniques 
such as PET and SPECT have found increases in glucose metabo-
lism and blood flow essentially at the frontal level after admin-
istration of the serotonergic psychedelics mescaline (Hermle 
et al., 1992), psilocybin (Vollenweider et al., 1997), and ayahuasca 
(Riba et  al., 2006). These studies, however, showed few or no 
effects at more posterior regions.
Drug-induced changes in parieto-occipital areas have been 
evidenced using electrophysiological measures. Studies of aya-
huasca-induced changes in brain oscillations (EEG) have found 
decreases in current density in frontomedial regions. However, 
more intense and widespread reductions have been located in 
the parietal cortex in an area centered on the posterior cingulate 
(Riba et al., 2004). Using magnetoencephalography (MEG), analo-
gous power reductions of magnetic signals in the posterior cin-
gulate and adjoining parietal areas have been found following 
intravenous psilocybin (Muthukumaraswamy et al., 2013).
Interactions between frontal and posterior areas have been 
described only recently. An MRI study of resting state has 
shown that acute administration of psilocybin decreases func-
tional coupling between prefrontal and parietal cortical midline 
regions, including the anterior and posterior cingulate corti-
ces (Carhart-Harris et al., 2012). Furthermore, long-term use of 
ayahuasca has been associated with opposite changes in brain 
structure in the anterior and posterior cingulate cortices in 
humans (Bouso et al., 2015).
The aim of this study was to assess the psychedelic-induced 
changes in the dynamic interaction of brain oscillations and 
the directionality of drug-induced modifications. We postulated 
that psychedelics modify neural hierarchies and the flow of 
information around the brain. To test this hypothesis, we stud-
ied directed functional connectivity of brain oscillations using 
transfer entropy (TE). This nonlinear measure identifies causal 
relationships, enabling the inference of directionality in the 
observed changes.
Materials and Methods
Participants and Drug Administration
We recruited a group of 10 healthy male volunteers with previ-
ous experience in psychedelic drug use. Prior to participation, 
all volunteers underwent a medical examination that included 
anamnesis, ECG, and standard laboratory tests to confirm good 
health. After being informed about the nature of ayahuasca 
and its general psychological and potential adverse effects, all 
volunteers gave their written informed consent to participate. 
The study was conducted in accordance with the Declaration 
of Helsinki and subsequent amendments concerning research 
in humans and was approved by the Hospital Ethics Committee 
and the Spanish Ministry of Health.
The study was conducted according to a double-blind, ran-
domized, balanced crossover design. EEG recordings, subjective 
effects measures, and plasma samples were obtained in 2 exper-
imental sessions 1 week apart. In one of the sessions, partici-
pants received a placebo and in another session they received 
an oral dose of ayahuasca. Ayahuasca was not administered in 
liquid form but as a freeze-dried formulation. Following lyophili-
zation, ayahuasca was homogenized, analyzed for alkaloid con-
tents, and encapsulated. The dose administered was equivalent 
to 0.75 mg DMT/kg body weight and was chosen as a medium-
intensity dose based on a previous study (Riba et  al., 2001b). 
Treatments were administered in a double-blind randomized 
fashion.
EEG Recording and Processing
Three-minute EEG recordings with eyes closed were recorded 
from 19 standard scalp leads (Fp1/2, F3/4, Fz, F7/8, C3/4, Cz, 
T3/4, T5/6, P3/4, Pz and O1/2). Recordings were obtained using 
a NeuroScan SynAmps amplifier (Compumedics Neuroscan, 
Charlotte, NC) before drug intake (baseline) and at 15, 30, and 
45 minutes, and 1, 1.5, 2, 2.5, 3, and 4 hours after administration. 
Signals were referenced to the averaged mastoid electrodes, and 
vertical and horizontal electrooculograms were also obtained 
for artifact minimization and rejection. Signals were analogi-
cally band-pass filtered between 0.1 and 45 Hz, digitized with 
a frequency of 250 Hz, and subsequently digitally resampled to 
100 Hz.
EEG artifact minimization and rejection was performed 
prior to parameter calculation. This was carried out following a 
previously described method based on blind source separation 
(Romero et al., 2008; Alonso et al., 2010). Subsequently, a 60-sec-
ond segment was cropped out and zero-phase filtered between 
0.5 and 35 Hz using a type-II Chebyshev filter of order 8.
TE Calculation
Following artifact reduction, TE was calculated. TE from y to x 
measures the amount of uncertainty reduced in the future val-
ues of x by taking into account the past values of y compared 
with when only the past values of x are used. Considering a 
delay of one sample in a time series (Schreiber, 2000), TE meas-
ures the increase in information obtained at xn+1 when xn and yn 
are known compared with the situation when only xn is known.
The information carried by a variable can be calculated by 
means of the Shannon entropy. If we consider 2 random vari-
ables, X and Y, with probability distribution functions p(x) and 
p(y) and the joint probability distribution function p(x,y), the 
Shannon entropy of X can be expressed as: 
Alonso et al. | 3
 
H(X) p(x)log p(x)
x
=− ( )∑
 
(1)
The Shannon entropy can be measured in bits if the base of the 
logarithm is 2. The joint Shannon entropy of the 2 variables will 
be: 
 
H(X Y) p(x y)log p(x y)
x y
, , ,
,
=− ( )∑
 
(2)
To obtain the expression of TE, we can consider the amount 
of additional information required to represent the value of a 
future observation of a signal by defining the following entropy 
rate for 2 signals: 
 
h p x ,x ,y log p x x ,y
p x ,x ,y log
p x
n 1 n n n 1 n n
x
n 1 n n
n 1
=− ( ) ( )( )=
− ( )
+ +
+
+
∑
n 1 n n
n nx
,x ,y
p x ,y
n 1
+( )
( )






+
∑
 
(3)
If we consider xn+1 independent from yn, equation 3 can be writ-
ten as: 
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TE is obtained by subtracting equation 4 from equation 3: 
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TE is inherently asymmetric, so that we can analogously define
TEx y→ : 
 
TE p y ,y ,x log
p y x ,y p y
p x ,y p y yx y n 1 n n
n 1 n n n
n n n 1 n
→ +
+
+
= ( ) ( )
( )
( ) ( )
,
,






+
∑
xn 1  
(6)
TE was estimated using a nonparametric methodology based on 
equiquantal binning, that is, estimating the probability distribution 
functions using marginal equiquantization and histograms. This 
procedure is recommended when sufficient data points are avail-
able (Vejmelka and Palus, 2008; Lee et al., 2012). While Lee et al. (2012) 
showed better results using KDE or D-V partitioning when fewer 
than 200 data points are used, our 60-second signals provided 6000 
data points and probability distributions could be estimated reliably.
Subjective Effect Measures and Blood Samples
The time course of subjective effects was measured using a 
100-mm visual analog scale. Participants were asked to rate 
the overall intensity of effects by drawing a vertical line cross-
ing the visual analog scale. This instrument was administered 
immediately before the administration of ayahuasca or placebo 
(baseline) and at 15, 30, and 45 minutes, and 1, 1.5, 2, 2.5, 3, and 
4 hours after dosing.
Additionally, volunteers were also requested to answer 2 
questionnaires measuring psychedelic-induced subjective 
effects. The first questionnaire was a Spanish version of the 
Hallucinogen Rating Scale (HRS) (Riba et  al., 2001a). The HRS 
includes 6 subscales: somaesthesia, reflecting somatic effects; 
affect, sensitive to emotional and affective responses; volition, 
indicating the incapacitation experienced; cognition, describ-
ing modifications in thought processes or content; perception, 
measuring visual, auditory, gustatory, and olfactory experi-
ences; and intensity, which reflects the strength of the overall 
experience.
The second questionnaire administered was a Spanish 
version of the Altered States of Consciousness Questionnaire 
(Aussergewöhnliche Psychische Zustände [APZ]) developed by 
Dittrich (1998). It includes 3 subscales: oceanic boundlessness 
(Ozeanische Selbstentgrenzung [OSE]), measuring changes in 
the sense of time, derealization, and depersonalization phenom-
ena; dread of ego-dissolution (Angstvolle IchAuflösung [AIA]), 
measuring thought disorder and decreased body and thought 
control associated with anxiety; and visionary restructuraliza-
tion (Visionäre Umstrukturierung [VUS]), measuring illusions, 
hallucinations, and synesthesia.
Participants completed the HRS and APZ at 4 hours following 
drug administration once the psychoactive effects of ayahuasca 
had worn off.
Blood samples were obtained immediately prior to drug 
administration (baseline) and at 0.5, 1, 1.5, 2, 2.5, 3, and 4 hours 
thereafter. DMT plasma concentrations were determined as pre-
viously published (Yritia et al., 2002).
Statistical Analysis
To investigate potential changes in TE induced by ayahuasca, a 
total of 19*18  =  342 connections were introduced in the analysis. 
To obtain the net pharmacological effect, the TE values obtained 
before drug intake (placebo or ayahuasca) were subtracted from 
post-drug values. Statistical differences between placebo and 
ayahuasca were then calculated.
Two-sided Wilcoxon signed-rank tests were carried out to 
search for differences at the different time-points. The results 
from the statistical tests were graphically presented using sche-
matic representations of electrodes on the scalp. Statistically 
significant comparisons between EEG leads were shown by 
connections between the corresponding electrodes. In these 
connection maps, warm colors indicated significant increases 
and cold colors indicated significant decreases. Thick, dark-
colored connections indicated statistically significant changes 
with P < .01 uncorrected, whereas thick and thin light-colored 
connections indicated P < .05 and .1, respectively. Connection 
maps were analyzed separately for increases and decreases. To 
assess the statistical significance of changes in directed con-
nectivity, we used these uncorrected thresholds, and then the 
significance of the functional disintegration over all connections 
was assessed using an omnibus statistic (the number of above 
threshold changes in directed connectivity). This omnibus test 
has been widely used in many studies in several fields such as 
primatology (Muniz et al., 2010), ecology (Verfuß et al. 2006), neu-
rology, and pharmacology (Saletu et al., 2004, 2005; Alonso et al., 
2010, Painold et al., 2011), among others. This statistic followed 
a binomial distribution under the null hypothesis of no changes 
anywhere (Cross and Chaffin, 1982). Thus, uncorrected P-values 
were treated as normalized effect sizes, but the multiple com-
parison problem was solved by reporting changes only when 
their number was significant. The connection maps shown in 
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the results section were only those with a number of significant 
changes (connections) exceeding the calculated threshold that 
was set at 44 according to the binomial criterion.
As TE is a directional measure, directionality maps were 
drawn showing the number of incoming or outgoing connec-
tions for each electrode. Thus, for each schematic representation 
showing increases and decreases of TE, 2 additional directional-
ity maps were drawn to show sources (outgoing information, 
green) and sinks (incoming information, gray). In each case, a 
color scale indicated intensity. The darkest tone (either green or 
gray) indicated 7 or more connections going in or out of the cor-
responding electrode and white indicated no connections.
These directionality maps, which indicated the origin and 
destination areas of the transferred information, were only cal-
culated if the prior connection maps were considered significant 
according to the uncorrected P-value.
Scores on the HRS and APZ questionnaires were compared 
between placebo and ayahuasca using Student’s t tests followed 
by correction for multiple comparisons using the false discovery 
rate. Results were considered significant for false discovery rate 
corrected P < .05.
Finally, data were explored for correlations between TE changes 
and subjective data (ayahuasca scores - placebo scores) and DMT 
plasma levels. Correlations were calculated using Pearson’s corre-
lation coefficient. Given the exploratory nature of this analysis, no 
correction for multiple comparisons was applied here.
Results
EEG Signals, TE
Compared with placebo, ayahuasca induced significant TE 
changes at 1.5, 2, and 2.5 hours following drug administration 
(Figure  1). As shown in the connection maps, significant 
increases of TE were observed for many electrode pairs at 2 
hours after ayahuasca administration. These increases were 
preceded and followed at 1.5 and 2.5 hours, respectively, by sig-
nificant decreases.
The directionality of change is shown in the figure below the 
connection maps. Topographic representations of the source and 
sink areas show that TE increases at 2 hours were governed by 
information originating at posterior leads (in green). This infor-
mation mainly influenced signals recorded at more frontal loca-
tions (in gray). In other words, uncertainty at frontal locations 
decreased, that is, predictability increased when information 
at posterior locations was taken into account. In contrast, the 
topographic maps corresponding to 1.5 and 2.5 hours showed 
that the TE decreases were caused by a reduced influence of 
information at anterior leads (in green) over signals at more 
posterior locations (in gray). In terms of predictability, poste-
rior activity became significantly less predictable when anterior 
signals were taken into account. The pattern of anterior-to-pos-
terior TE decreases and posterior-to-anterior TE increases was 
observed at all time points between 45 minutes and 4 hours 
following drug administration. However, statistical signifi-
cance was reached only at the time points mentioned above. In 
the supplementary Material file, we include the directionality 
maps for all time-points irrespective of statistical significance. 
This approach showed that the pattern of ayahuasca-induced 
changes in TE was consistent throughout the duration of aya-
huasca effects.
Subjective Effects and DMT Plasma Levels
As shown in Figure 2, parallel variations were observed between 
TE, the time course of subjective effects, and DMT plasma 
Figure 1. Results of the statistical test are shown on schematic representations of electrodes on the scalp. Significant changes are shown by connections between the 
corresponding electrodes. Warm colors indicate significant increases (first row) and cold colors (second row) indicate significant decreases. Thick, dark-colored con-
nections indicate statistically significant changes with P < .01, whereas thick and thin light-colored connections indicate P < .05 and 0.1, respectively. Connections are 
shown only if their number in the connections map was above the threshold set by the binomial criterion. Otherwise, no connections are depicted, because they are 
considered a random result not due to drug administration (see text). The connection maps for the time points that are not shown had a lower number of significant 
connection changes, and they were considered not relevant based on the binomial criterion. The third and fourth rows show the directionality maps depicting the 
number of outgoing (in green) or incoming (in gray) connections for each electrode, respectively. In each case, a 7-level color scale indicates intensity. Note that the 
darkest tone indicates 6 or more connections going in or out of the corresponding electrode, and white indicates no connections.
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concentrations. The maximum values for each of these meas-
ures were observed between 1.5 and 2.5 hours following admin-
istration. Scores on the HRS and APZ questionnaires are shown 
in Table  1. Compared with placebo, ayahuasca induced sta-
tistically significant increases in all 6 subscales of the HRS. In 
the APZ, the VUS subscales were significantly increased, while 
nonsignificant elevations were observed in the OSE and AIA 
subscales.
Correlation Analysis
Mean TE values for the time period 1.5 to 2.5 hours were cal-
culated for electrode pairs that showed statistically significant 
differences from placebo. These mean values were correlated 
with scores on the HRS and APZ questionnaires. Significant 
correlations were found for TE decreases, for example, in the 
FP2→P3 pair and the HRS scales perception (r = -0.640, P = .046), 
cognition (r = -0.665, P = .036), and intensity (r = -0.736, P = .015). 
Also between TE decreases in the FP2→P3 pair and the APZ 
scales OSE (r = -0.705, P = .023), AIA (r = -0.684, P = .029), and VUS 
(r = -0.678, P = .031) (see Figure  3). No correlations were found 
for posterior to anterior TE increases. We subsequently tested 
whether the ayahuasca-induced imbalance between anterior-
to-posterior and posterior-to-anterior information transfer was 
associated with the subjective experience. To do so, we calcu-
lated the difference values between anterior-to-posterior and 
posterior-to-anterior TE for the different electrode pairs (for 
instance, the difference value (Fp2→P3)-(Pz→F8)). We found that 
values calculated this way were significantly correlated with the 
HRS volition scale: [(Fp2→P3)-(Pz→F8); r = -0.666, P = .036], and 
[(Fp2→P3)-(Pz→F7); r = -0.654, P = .040].
Data Reanalysis Using Granger Causality
To assess the robustness of the TE findings, we conducted a 
reanalysis of the data at the 2-hour time point using Granger 
Causality (GC). TE is a model-free generalization of GC and is 
equivalent to the latter for data following a normal distribution 
(Barnett et  al., 2009). However, GC is a more commonly used 
approach to functional connectivity in the field of neurosci-
ence. Its mathematical formulation is based on linear regression 
modeling of stochastic processes (Granger, 1969).
GC calculations were implemented using the MVGC multi-
variate GC toolbox (Barnett and Seth, 2014) using the work-flow 
recommended by the authors. An optimal model order of 8 was 
used (according to the Akaike Information Criterion), although 
we also tested orders 4 and 16 to look for possible differences 
regarding the VAR model estimation. The resulting causalities 
were evaluated following the experimental design (baseline cor-
rection and compared with placebo).
The results of the reanalysis are shown in Figure 4. Significant 
increases in postero-anterior connections were observed, 
although their number was lower than with TE. The number 
of significant connections also varied slightly between model 
order, but the overall pattern of results is analogous to our origi-
nal analysis, supporting the conclusions reached using TE.
Discussion
The directed functional connectivity analysis reported here 
showed psychedelic-induced changes in antero-posterior cou-
pling of electrophysiological brain oscillations. Acute adminis-
tration of ayahuasca altered brain dynamics, as measured by TE. 
As opposed to other connectivity measures such as coherence 
Figure  2. Time course of the number of significant changes induced by aya-
huasca administration detected by transfer entropy (TE; yellow bars). The red 
and green traces show the N,N-dimethyltryptamine (DMT) concentration and 
visual analog scale scores, respectively.
Figure 3. Scatter plots showing the relationship between mean transfer entropy 
(TE) values for the time period 1.5 to 2.5 hours and Hallucinogen Rating Scale 
(HRS) scores.
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or mutual information, TE identifies directed causal relation-
ships enabling the inference of directionality in the observed 
changes. Note that a pair-wise estimate of TE was used, mean-
ing that information flow from all other regions was not taken 
into account when considering the directed functional connec-
tivity between any 2 nodes. In other words, it is possible that 
some of the reproduced dependencies may have varied if infor-
mation transfer from other nodes had been taken into account. 
However, this does not really matter, because our primary 
results stand in terms of directed statistical dependencies and 
their changes due to psychopharmacological effects.
Results showed that ayahuasca acutely decreased anterior-
to-posterior information transfer and increased posterior-
to-anterior information transfer. These neurophysiological 
changes ran parallel to DMT plasma concentrations and subjec-
tive effects. These findings suggest that psychedelics transiently 
disrupt neural hierarchies by modifying information transfer 
between brain regions. These results were further supported by 
a reanalysis of the data using GC. Again, posterior-to-anterior 
connectivity increases were observed at the 2-hour time point. 
However, the number of significant connections was lower than 
with TE, possibly because of the length of the signals and minor 
local nonstationarities, to which the equiquantal binning-based 
estimation of TE is quite robust.
The present results combine the high temporal resolution of 
neurophysiological measures with the directionality informa-
tion provided by TE and add to anatomical data available from 
neuroimaging techniques. Various studies have highlighted the 
medial aspects of the frontal and parietal cortices as key struc-
tures involved in the modified states of awareness induced by 
psychedelics. Nuclear medicine studies using PET and SPECT 
have emphasized increased blood perfusion and glucose metab-
olism in several frontomedial regions, including the ACC. Such 
increases have been observed following the classic serotoner-
gic psychedelics mescaline and psilocybin (Hermle et al., 1992; 
Vollenweider et al., 1997) and after subanesthetic doses of the 
glutamatergic NMDA receptor antagonist ketamine (Daumann 
et al., 2010). Similarly, in a previous SPECT study by our group, we 
also found increases in blood flow in frontomedial regions after 
acute ayahuasca administration (Riba et al., 2006).
Despite converging evidence from the various radiotracer 
studies, analysis of drug-induced changes in brain oscillations 
has yielded only partially overlapping results. Source localiza-
tion studies of ayahuasca-induced changes on the EEG found 
significant modifications in current density in the ACC and 
neighboring areas, but also in parietal and occipital cortex (Riba 
et al., 2004). Here, we have replicated these results in a current 
density analysis that we report in the supplementary Figure 
S2 and associated text. Thus, we found broadband reductions 
in current density in medial posterior (precuneus and cuneus) 
and anterior (cingulate) brain areas. A  recent MEG study has 
extended these findings to psilocybin and magnetic signals. 
The results highlighted the parietal cortex as the main site of 
broadband oscillatory decreases acutely induced by the drug 
Table 1. Subjective Effects Induced by Placebo and Ayahuasca (0.75 mg DMT/kg Body Weight)
HRS Placebo Ayahuasca
Student’s t Test
Significance
(FDR Corrected)t value P value
 Somaesthesia 0.00 (0.00) 1.15 (1.01) -3.56 .006 *
 Affect 0.27 (0.06) 1.27 (0.90) -3.52 .007 *
 Perception 0.00 (0.00) 1.28 (1.14) -3.56 .006 *
 Cognition 0.00 (0.00) 1.21 (1.09) -3.52 .007 *
 Volition 0.33 (0.50) 1.11 (0.56) -3.92 .003 *
 Intensity 0.10 (0.32) 1.93 (1.03) -5.98 .000 *
APZ
 OSE 0.10 (0.32) 4.00 (4.27) -2.88 .018 n.s.
 AIA 0.00 (0.00) 3.40 (5.60) -1.92 n.s n.s.
 VUS 0.00 (0.00) 5.60 (5.21) -3.40 .008 *
Abbreviations: AIA, dread of ego dissolution; APZ, Aussergewöhnliche Psychische Zustände; FDR, false discovery rate; HRS, Hallucinogen Rating Scale; OSE, oceanic 
boundlessness; VUS, visionary restructuralization.
Means (SD) of the scores obtained for the HRS and APZ questionnaires and results of the statistical analysis. n = 10. Results were corrected for multiple comparisons 
using the FDR, which yielded a threshold value for significance of P = .0180.
*Significant following FDR correction, n.s., not significant.
Figure 4. Reanalysis of functional connectivity at the 2-hour time point using 
Granger Causality (GC) with model orders of 4, 8, and 16. Significant changes 
are shown in the first row by lines connecting the corresponding electrodes and 
indicate increases. Thick, dark lines indicate statistically significant increases 
with P <. 01, whereas thick and thin light-colored lines indicate increases with 
P <. 05 and 0.1, respectively. The second and third rows show the directionality 
maps showing the number of outgoing (green) or incoming (gray) connections 
for each electrode, respectively. In each case, a 7-level color scale indicates inten-
sity. Note that the darkest tone indicates 6 or more connections going in or out of 
the corresponding electrode, and white indicates no activity.
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(Muthukumaraswamy et  al., 2013). These seemingly paradoxi-
cal effects involving energy decreases in EEG and MEG and 
simultaneously enhanced visual activity can be interpreted in 
light of multiple-technique studies. An early study involving 
topographic electroencephalography and PET already found an 
inverse relationship between alpha power and cerebral glucose 
use (Buchsbaum et al., 1984). More recently, combined studies 
using BOLD and EEG found a negative correlation between alpha 
and BOLD in the anterior cingulate and parieto-occipital cor-
tex, especially in visual areas (Goldman et al., 2002; Laufs et al., 
2003; de Munck et al., 2007). Thus, a decreased alpha rhythm has 
been associated with metabolic activation (Moosmann et  al., 
2003). These findings have recently been extended to other fre-
quency bands of the EEG, including theta and beta (de Munck 
et  al., 2009). The observed broad-band power decreases found 
after ayahuasca in the current source density analysis can be 
interpreted as reflecting increased activation of areas involved 
in visual processing (occipital cortex) and cognitive-emotional 
processing (ACC).
TE results in the present study show that functional coupling 
of EEG signals is altered in the psychedelic state and predomi-
nantly so along the anterior-to-posterior axis. Our analysis of 
directed functional connectivity using TE shows the involve-
ment of both the anterior and posterior brain, combining the 
partial findings of the more classical techniques mentioned 
above. Our analysis shows that psychedelics temporarily modify 
the dynamics of the interaction between the higher order fron-
tal regions and the more sensory-selective posterior areas. In 
line with our TE data, a study in rodents has also shown psy-
chedelic-induced changes in the functional coupling of EEG 
signals between frontal and parietal sites. The psychedelic 
phenethylamine 2C-B increased EEG connectivity in these ani-
mals (Páleníček et al., 2013). In another study, increased coher-
ence was reported in the high-frequency bands after ayahuasca 
administration (Stuckey et  al., 2005). Additional evidence of 
modified functional coupling between frontal and parietal 
regions in the psychedelic state was recently provided by a mag-
netic resonance imaging study of psilocybin effects in humans 
(Carhart-Harris et al., 2012). Following the intravenous admin-
istration of the drug, the authors reported increases in BOLD 
signal coupling between the anterior and posterior cingulate 
cortices. Their approach, however, did not provide information 
on potential changes in the direction of information flow.
Inference of directionality can be made with TE. Our data 
indicate a decrease in the predictability of activity in posterior 
areas based on information available at anterior sites and, con-
versely, an increase in the predictability of activity in anterior 
areas when information at posterior sites is taken into account. 
In other words, the hierarchies governing the flow of informa-
tion observed after placebo are transiently disrupted by psych-
edelics. These findings can be interpreted in light of emerging 
theoretical views of brain function. Bayesian inference models 
postulate that the subjective experience of reality emerges from 
the dynamic interaction between bottom-up or feed-forward 
sensory information and top-down or feedback projections 
that interpret incoming signals based on previous knowledge 
and expectations (Friston, 2005; Mesulam, 2008). In this theo-
retical framework, the frontal cortex is at the top of the hier-
archy, sending backward projections that modulate incoming 
information according to a series of constraints. This particu-
lar finding of asymmetrical changes in top-down connections 
from the prefrontal cortex is interesting in relation to the find-
ings of Boly et al. (2011), who used dynamic causal modelling to 
show a selective impairment of top-down frontal connectivity in 
impaired consciousness.
We speculate that when top-down constraints are reduced 
and sensory excitability is increased (de Araujo et  al., 2012), 
weak endogenous activity or “system noise” in visual and audi-
tory cortices is then able to reach higher levels in the hierarchy. 
This could explain the visual phenomena commonly reported 
for psychedelics. These visual effects are typically more prom-
inent with eyes closed when “system noise” does not have to 
compete with strong external visual stimuli (Riba et al., 2001b). 
Higher excitability at the posterior heteromodal association cor-
tex, the cingulate, and other paralimbic structures (Riba et al., 
2004, 2006) could explain the “seepage” of information between 
sensory modalities causing synesthesia and the high emotional 
lability induced by psychedelics (Riba et al., 2001b). In the study 
by Muthukumuraswarmy and coworkers (2013), dynamic causal 
modelling revealed that posterior cingulate desynchronization 
can be explained by increased excitability of deep layer pyrami-
dal neurons, which are known to be rich in 5HT2A receptors. 
This fits comfortably with our findings in relation to TE in the 
sense that the posterior regions come to dominate information 
outflow to other (eg, prefrontal) regions. This higher excitability 
combined with the loosening of the cognitive grip exerted by 
frontal regions responsible for executive control may underlie 
the overwhelming nature of the experience. In addition to drug 
potency and dose, we can postulate that these interactions will 
also be modulated by factors affecting each individual, such as 
mood, personality, expectations, and prior experience with psy-
chedelic drugs. Thus, the perceptual modifications, associations, 
and insights that emerge will not only vary between individuals 
but also from one intake to the next, making each psychedelic 
experience novel and surprising (Shanon, 2002).
It can be argued that if this disruption of hierarchies were to 
linger after discontinuation of the drug, problems could emerge 
in the normal processing of sensory information. Longer-lasting 
changes at this level could explain some of the adverse conse-
quences associated with psychedelic drug use. The hallucino-
gen persistent perception disorder, an infrequent but highly 
distressing disorder (Halpern and Pope, 2003), could reflect a 
chronic impairment of functional coupling. In a study examin-
ing EEG connectivity in chronic LSD users suffering from hal-
lucinogen persistent perception disorder, the authors found 
increased intra-occipital coherence and decreased coherence 
between posterior and frontal sites (Abraham and Duffy, 2001). 
Additionally, they reported a decreased latency of the P200 com-
ponent of the visual evoked potential. The authors had previ-
ously speculated that pathological disinhibition of posterior 
cortical activity could be responsible for the visual phenomena 
reported by the patients (Abraham and Duffy, 1996).
To sum up, acute administration of a psychedelic disrupted 
the functional connectivity of brain oscillations in humans. TE 
measures showed that signals at frontal locations decreased 
their influence over oscillations at more posterior sites. 
Conversely, sources in posterior locations increased their influ-
ence over signals measured at anterior locations. Drug-induced 
modifications in TE were associated with the intensity and time 
course of subjective effects. These results suggest that psych-
edelics induce a temporary disruption of neural hierarchies 
governing the flow of information by reducing top-down control 
and enhancing bottom-up information transfer. These changes 
could underlie the profound modifications of perception, cog-
nitive processes, and experience of reality typically induced by 
these drugs.
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